Niitaka Co., Ltd. (TSE:4465) acquired 90% stake in Biobank Co., Ltd. on March 28, 2023. As part of acquisition 460 shares acquired. For period ended March 31, 2022, Biobank reported Net worth of ¥1.5 billion, total assets of ¥1.9 billion, sales of ¥950 million, operating income of ¥143 million and net income of ¥99 million.

Niitaka Co., Ltd. (TSE:4465) completed the acquisition of 90% stake in Biobank Co., Ltd. on March 28, 2023.